Prestige Biologics Co., Ltd. (KOSDAQ:334970)

South Korea · Delayed Price · Currency is KRW

1,408.00

+2.00 (0.14%)

At close: Oct 8, 2026

Market Cap	109.48B -55.9%
Revenue (ttm)	26.67B +112.8%
Net Income	-51.22B
EPS	-658.76
Shares Out	77.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,543
Open	1,419.00
Previous Close	1,406.00
Day's Range	1,372.00 - 1,451.00
52-Week Range	1,230.00 - 3,850.00
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Prestige Biologics

Prestige Biologics Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers budget finding, contract development, contract manufacturing, contract packaging, and analytical testing services. It also provides customized engineering solutions for manufacturing process under the ALITA Smart BioFactory brand name. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was incorporated in 2015 and is based in Cheongju... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2015

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 334970

Full Company Profile

Financial Performance

In fiscal year 2026, Prestige Biologics's revenue was 26.67 billion, an increase of 112.75% compared to the previous year's 12.53 billion. Losses were -51.22 billion, 86.5% more than in 2025.

Financial Statements